| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| nitd609 | adenosine a3 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malaria[MeSHID:D008288] |
0.8 | phase 2 | unknown |
| nitd609 | voltage-gated potassium channel kv11.1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malaria[MeSHID:D008288] |
0.09 | phase 2 | unknown |
| click here to return to the previous page | ||||||||